Touchstone International Medical Science Co Ltd Net Asset Quality Index
Touchstone International Medical Science Co Ltd net asset quality index. Touchstone International Medical Science Co Ltd (688013) has a Net Asset Quality Index of 88.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥676.02 Million minus total liabilities of CN¥76.41 Million yields net assets of CN¥599.62 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Touchstone International Medical Science book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Touchstone International Medical Science Co Ltd (2017–2024)
Net asset quality index of Touchstone International Medical Science Co Ltd from 2017 to 2024. This chart shows how Touchstone International Medical Science Co Ltd's Net Asset Quality Index has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the index stands at 88.7%, representing net assets of CN¥599.62 Million against total assets of CN¥676.02 Million CNY. Check asset allocation strategy of Touchstone International Medical Science to assess the company's strategic physical and investment asset allocation.
Touchstone International Medical Science Co Ltd Net Asset Quality Index by Year (2017–2024)
Touchstone International Medical Science Co Ltd net asset quality index by year from 2017 to 2024. The table below presents the year-by-year Net Asset Quality Index for Touchstone International Medical Science Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Touchstone International Medical Science market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 91.2% | CN¥581.43 Million | CN¥637.24 Million | CN¥55.81 Million | ▲ +0.0 pp |
| 2023 | 91.2% | CN¥571.52 Million | CN¥626.61 Million | CN¥55.08 Million | ▼ -2.3 pp |
| 2022 | 93.6% | CN¥508.41 Million | CN¥543.46 Million | CN¥35.04 Million | ▼ -0.4 pp |
| 2021 | 94.0% | CN¥512.13 Million | CN¥544.83 Million | CN¥32.71 Million | ▼ -2.0 pp |
| 2020 | 96.0% | CN¥465.89 Million | CN¥485.24 Million | CN¥19.35 Million | ▲ +10.2 pp |
| 2019 | 85.8% | CN¥107.18 Million | CN¥124.91 Million | CN¥17.72 Million | ▲ +14.9 pp |
| 2018 | 70.9% | CN¥82.90 Million | CN¥116.95 Million | CN¥34.05 Million | ▼ -10.1 pp |
| 2017 | 81.0% | CN¥79.84 Million | CN¥98.57 Million | CN¥18.72 Million | — |